FIELD: medicine. SUBSTANCE: product: azasteroidal compounds of general formula I wherein is H, unsubstituted R1 alkyl, benzyl; C1-C4 is R2-C1-C4-alkyl substituted by phenyl, furyl or thienyl group; R3 is H, unsubstituted C1-C4-alkyl, C1-C4-alkyl substituted by hydroxy or carboxy group or R3 is C3-C6 alkenyl, A-B and C-D are carbon-carbon single or double bonds; said phenyl groups may be substituted by at least by one substituent such as C1-C6-alkyl, C1-C4-alkoxy, C2-C4- alkoxycarbonyl, hydroxy-, halogen, acetoamido group. 62 individual compounds are claimed in claim 2. Compounds I are capable of inhibiting 5-α-reductase. EFFECT: improved properties of the azasteroidal compounds. 4 tbl
Title | Year | Author | Number |
---|---|---|---|
STEROID COMPOUNDS, METHOD OF THEIR SYNTHESIS | 1993 |
|
RU2097387C1 |
3-CYANOANDROSTA-3,5-DIENE-17BETA-CARBOXYLIC ACID AS INTERMEDIATE PRODUCT, AND METHOD OF PREPARING COMPOUNDS | 1993 |
|
RU2114861C1 |
BENZOPYRAN DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, AND A METHOD OF THEIR SYNTHESIS | 1991 |
|
RU2038354C1 |
CRYSTALLINE PIVALOYLHYDROXYMETHYL-(1R, 5S, 6S)-[(4R)-2-OXO-4--PYRROLIDINYLTHIO]-6-[(1R)-1-HYDROXYETHYL]-1-METHYL-1-CARBAPE--NE-2-EME-3-CARBOXYLATE AND METHOD OF ITS SYNTHESIS | 1993 |
|
RU2090567C1 |
LIPID ANALOGS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1992 |
|
RU2076107C1 |
FOUR-COORDINATION COMPLEXES OF DIVALENT PLATINUM | 1992 |
|
RU2039064C1 |
AZETIDINONE DERIVATIVES AND A METHOD OF THEIR SYNTHESIS | 1992 |
|
RU2047602C1 |
CARBOPENEM DERIVATIVES AND A METHOD OF THEIR SYNTHESIS | 1993 |
|
RU2097383C1 |
α, ω-DIARYL ALKANES AND METHOD FOR THEIR PRODUCTION | 1993 |
|
RU2105752C1 |
COMPOSITION FOR TREATMENT OR PROPHYLAXIS OF PROSTATE CANCER | 1998 |
|
RU2196582C2 |
Authors
Dates
1996-12-10—Published
1991-10-28—Filed